母胎界面CD56bright自然杀伤细胞的免疫调节功能及其在妊娠中的作用
The Immunoregulatory Function of CD56bright Natural Killer Cells at the Maternal-Fetal Interface and Their Role in Pregnancy
摘要: 自然杀伤细胞在母胎界面处的独特表现与功能是成功建立和维持妊娠的关键。与外周血中以细胞毒性为主的Cd56dim Nk细胞亚型不同,孕期母胎界面中的Nk细胞主要为Cd56bright表型,这一群体具有低细胞毒性、高分泌性的特点,在母胎免疫耐受和胎盘形成中扮演着核心角色。本综述旨在系统阐述母胎界面Nk细胞,特别是Cd56bright亚群,在妊娠中的调节功能。首先,我们将重点分析Cd56bright Nk细胞通过分泌多种细胞因子介导的免疫调节与促进螺旋动脉重铸的功能,这是确保胎儿充足血供的基础。其次,我们将深入探讨母胎界面的特殊微环境如何精细调控Nk细胞的功能,其中,胎盘滋养细胞特异性表达的非经典Mhc-I分子Hla-G通过与Nk细胞表面的抑制性受体的相互作用,在建立局部免疫耐受中发挥至关重要的作用;同时,蜕膜基质细胞等通过分泌细胞因子共同构成了一个独特的免疫调节网络。此外,本综述还将讨论当这些调节机制失衡时,如何可能导致复发性流产、子痫前期等妊娠相关疾病的发生。最后,我们将展望该领域未来的研究方向,包括探索Nk细胞与其他免疫细胞的相互作用,以及基于Nk细胞功能调控的潜在治疗策略。通过整合最新文献,本文旨在为深入理解母胎免疫耐受的机制和妊娠疾病的病理生理提供全面的视角。
Abstract: Natural killer (NK) cells at the maternal-fetal interface exhibit unique phenotypic and functional features that are essential for the successful establishment and maintenance of pregnancy. In contrast to peripheral blood CD56dim NK cells, which are primarily cytotoxic, decidual NK cells during pregnancy are predominantly of the CD56bright phenotype. This subset is characterized by low cytotoxicity and a high secretory capacity, playing a central role in maternal-fetal immune tolerance and placental development. This review aims to systematically summarize the regulatory functions of maternal-fetal interface NK cells, with a particular focus on the CD56bright subpopulation. First, we highlight how CD56bright NK cells mediate immune regulation and promote spiral artery remodeling through the secretion of diverse cytokines, thereby ensuring adequate uteroplacental blood flow. Second, we explore the specialized microenvironment of the maternal-fetal interface that finely tunes NK cell function. In this context, the non-classical MHC-I molecule HLA-G, selectively expressed by trophoblasts, engages inhibitory receptors on NK cells and plays a pivotal role in establishing local immune tolerance. Decidual stromal cells further contribute to this regulatory network via cytokine secretion. Furthermore, we discuss how dysregulation of these mechanisms may contribute to pregnancy-related complications, including recurrent miscarriage and preeclampsia. Finally, we outline future research directions, such as elucidating the interactions between NK cells and other immune populations and developing therapeutic strategies targeting NK cell functionality. By integrating recent advances, this review provides a comprehensive perspective on the mechanisms underlying maternal-fetal immune tolerance and the pathophysiology of pregnancy disorders.
文章引用:蔡仓庆, 黄钧豪. 母胎界面CD56bright自然杀伤细胞的免疫调节功能及其在妊娠中的作用[J]. 临床医学进展, 2026, 16(7): 1633-1640. https://doi.org/10.12677/acm.2026.1672684

参考文献

[1] Mao, J., Feng, Y., Zhu, X. and Ma, F. (2023) The Molecular Mechanisms of HLA-G Regulatory Function on Immune Cells during Early Pregnancy. Biomolecules, 13, Article 1213. [Google Scholar] [CrossRef] [PubMed]
[2] Rajagopalan, S. (2014) HLA-G-Mediated NK Cell Senescence Promotes Vascular Remodeling: Implications for Reproduction. Cellular & Molecular Immunology, 11, 460-466. [Google Scholar] [CrossRef] [PubMed]
[3] Dogra, P. and Farber, D.L. (2020) Stealth Killing by Uterine NK Cells for Tolerance and Tissue Homeostasis. Cell, 182, 1074-1076. [Google Scholar] [CrossRef] [PubMed]
[4] Lee, C., Vijayan, M., Wang, X., Lam, K.K.W., Koistinen, H., Seppala, M., et al. (2018) Glycodelin—A Stimulates the Conversion of Human Peripheral Blood Cd16-CD56bright NK Cell to a Decidual NK Cell-Like Phenotype. Human Reproduction, 34, 689-701. [Google Scholar] [CrossRef] [PubMed]
[5] Fu, B., Li, X., Sun, R., Tong, X., Ling, B., Tian, Z., et al. (2012) Natural Killer Cells Promote Immune Tolerance by Regulating Inflammatory TH17 Cells at the Human Maternal-Fetal Interface. Proceedings of the National Academy of Sciences, 110, E231-E240. [Google Scholar] [CrossRef] [PubMed]
[6] Chen, S., Zhu, H. and Jounaidi, Y. (2024) Comprehensive Snapshots of Natural Killer Cells Functions, Signaling, Molecular Mechanisms and Clinical Utilization. Signal Transduction and Targeted Therapy, 9, Article No. 302. [Google Scholar] [CrossRef] [PubMed]
[7] Liu, S., Liang, J., Yang, D., Yang, L., Cai, S., Wang, L., Yin, T. and Diao, L. (2025) Trained Immunity in Pregnancy: Impact on Maternal-Fetal Outcomes and Mechanistic Insights. Placenta, 180, 79-86.
[8] Vikberg, S., Lindau, R., Stikvoort, A., Solders, M., Gorchs, L., Oudshoorn, J., et al. (2025) Placental Intervillous Blood Harbors NK Cells with Distinct Tissue-Resident Characteristics. Mucosal Immunology, 19, 1561-1572.
[9] Niehrs, A., Hertwig, L., Buggert, M., Nordström, I., Statzu, M., Pampena, M.B., et al. (2025) Transient Tissue Residency and Lymphatic Egress Define Human CD56bright NK Cell Homeostasis. Nature Immunology, 26, 2004-2015. [Google Scholar] [CrossRef
[10] Solt, I., Dominsky, O., Ben David, C., Admati, I., Cohen, S.M. and Yagel, S. (2025) Genomic Insights at the Maternal-Fetal Interface: Preeclampsia Subtypes and Clinical Implications. Arteriosclerosis, Thrombosis, and Vascular Biology, 45, 1724-1731. [Google Scholar] [CrossRef
[11] 李芸芸, 林懿空, 李大金, 杜美蓉. NK细胞在早孕期母-胎界面的功能[J]. 现代免疫学, 2019, 39(2): 145-149.
[12] Horwitz, D.A., Kim, D., Kang, C., Brion, K., Bickerton, S. and La Cava, A. (2025) CD2-Targeted Nanoparticles Encapsulating IL-2 Induce Tolerogenic Tregs and TGF-β-Producing NK Cells That Stabilize Tregs for Long-Term Therapeutic Efficacy in Immune-Mediated Disorders. Frontiers in Immunology, 16, Article ID: 1587237. [Google Scholar] [CrossRef] [PubMed]
[13] Vacca, P., Chiossone, L., Mingari, M.C. and Moretta, L. (2019) Heterogeneity of NK Cells and Other Innate Lymphoid Cells in Human and Murine Decidua. Frontiers in Immunology, 10, Article No. 170. [Google Scholar] [CrossRef] [PubMed]
[14] Andraweera, P.H., Dekker, G.A. and Roberts, C.T. (2012) The Vascular Endothelial Growth Factor Family in Adverse Pregnancy Outcomes. Human Reproduction Update, 18, 436-457. [Google Scholar] [CrossRef] [PubMed]
[15] Melsen, J.E., Lugthart, G., Lankester, A.C. and Schilham, M.W. (2016) Human Circulating and Tissue-Resident CD56bright Natural Killer Cell Populations. Frontiers in Immunology, 7, Article ID: 262. [Google Scholar] [CrossRef] [PubMed]
[16] Hanna, J., Goldman-Wohl, D., Hamani, Y., Avraham, I., Greenfield, C., Natanson-Yaron, S., et al. (2006) Decidual NK Cells Regulate Key Developmental Processes at the Human Fetal-Maternal Interface. Nature Medicine, 12, 1065-1074. [Google Scholar] [CrossRef] [PubMed]
[17] Emmer, P.M. (2003) HLA-G, Immunocompetent Cells and Pregnancy Outcome: A Case of Modulation. Doctoral Dissertation, Katholieke Universiteit Nijmegen.
[18] Zhu, Y., Liu, X., Xu, Y. and Lin, Y. (2023) Hyperglycemia Disturbs Trophoblast Functions and Subsequently Leads to Failure of Uterine Spiral Artery Remodeling. Frontiers in Endocrinology, 14, Article ID: 1060253. [Google Scholar] [CrossRef] [PubMed]
[19] Yull, S. (2025) Pregnancy Success Is Dependent on Nodal Expression during The Pre-Implantation Period and the Establishment of a Tolerant Maternal Immune Environment. Master’s Thesis, Mcgill University.
[20] Rouas-Freiss, N., Moreau, P., LeMaoult, J., Papp, B., Tronik-Le Roux, D. and Carosella, E.D. (2021) Role of the HLA-G Immune Checkpoint Molecule in Pregnancy. Human Immunology, 82, 353-361. [Google Scholar] [CrossRef] [PubMed]
[21] Li, W., Zheng, G. and Zhang, S. (2025) Emerging Roles of KIR2DL4 in Cancer Immunotherapy. Breast Cancer, 32, 885-891. [Google Scholar] [CrossRef] [PubMed]
[22] Li, C., Houser, B.L., Nicotra, M.L. and Strominger, J.L. (2009) HLA-G Homodimer-Induced Cytokine Secretion through HLA-G Receptors on Human Decidual Macrophages and Natural Killer Cells. Proceedings of the National Academy of Sciences of the United States of America, 106, 5767-5772.
[23] 栗一帆, 梁志伟. 人类白细胞抗原-G与免疫耐受的研究进展[J]. 器官移植, 2012, 3(2): 108-111.
[24] Gan, J. and Yan, W. (2018) Roles of Human Leukocyte Antigen G (HLA-G) in MDSC Proliferation, M1/M2 Macrophage Differentiation and Tumor Immune Evasion. Journal of Cellular and Molecular Medicine, 22, Article 1076263.
[25] Jabrane-Ferrat, N. (2019) Features of Human Decidual NK Cells in Healthy Pregnancy and during Viral Infection. Frontiers in Immunology, 10, Article ID: 1397. [Google Scholar] [CrossRef] [PubMed]
[26] Harris, L.K. (2011) IFPA Gabor than Award Lecture: Transformation of the Spiral Arteries in Human Pregnancy: Key Events in the Remodelling Timeline. Placenta, 32, S154-S158. [Google Scholar] [CrossRef] [PubMed]
[27] Pashazadeh, M. (2024) Investigation of Immune Cell Interactions to Promote Maternal and Fetal Health in a Healthy Pregnancy. Comprehensive Health and Biomedical Studies, 3, 158-176. [Google Scholar] [CrossRef
[28] Zhang, P. (2018) CD56 Expression of Intravascular Trophoblasts Defines a Class of Vasculopathy in Preeclampsia and Other Pregnancy Complications. bioRxiv.
[29] Rajagopalan, S. and Long, E.O. (1999) A Human Histocompatibility Leukocyte Antigen (HLA)-G-Specific Receptor Expressed on All Natural Killer Cells. The Journal of Experimental Medicine, 189, 1093-1100. [Google Scholar] [CrossRef] [PubMed]
[30] Poli, A., Michel, T., Thérésine, M., Andrès, E., Hentges, F. and Zimmer, J. (2009) Cd56bright Natural Killer (NK) Cells: An Important NK Cell Subset. Immunology, 126, 458-465. [Google Scholar] [CrossRef] [PubMed]
[31] Ma, Y., Qian, Y., Jiang, H., Meng, H., Wang, Y. and Yang, Y. (2024) Combined Maternal KIR2DL4 and Fetal HLA-G Polymorphisms Were Associated with Preeclampsia in a Han Chinese Population. Frontiers in Genetics, 15, Article ID: 1442938. [Google Scholar] [CrossRef] [PubMed]
[32] Yamamoto, M., Fukui, A., Mai, C., Saeki, S., Takayama, R., Wakimoto, Y., et al. (2022) Evaluation of NKp46 Expression and Cytokine Production of Decidual NK Cells in Women with Recurrent Pregnancy Loss. Reproductive Medicine and Biology, 21, e12478. [Google Scholar] [CrossRef] [PubMed]
[33] Zheng, G., Jia, L. and Yang, A. (2022) Roles of HLA-G/KIR2DL4 in Breast Cancer Immune Microenvironment. Frontiers in Immunology, 13, 791975. [Google Scholar] [CrossRef] [PubMed]
[34] Abramova, M.Y. and Churnosov, M.I. (2021) Modern Concepts of Etiology, Pathogenesis and Risk Factors for Preeclampsia. Journal of Obstetrics and Womens Diseases, 70, 105-116. [Google Scholar] [CrossRef
[35] Jin, X., Cui, L., Zhao, W., Li, X., Liu, L., Li, Y., et al. (2021) Decidualization-Derived cAMP Regulates Phenotypic and Functional Conversion of Decidual NK Cells from CD56dimCD16-NK Cells. Cellular & Molecular Immunology, 18, 1596-1598. [Google Scholar] [CrossRef] [PubMed]
[36] Rebuffet, L., Melsen, J.E., Escalière, B., Basurto-Lozada, D., Bhandoola, A., Björkström, N.K., et al. (2024) High-Dimensional Single-Cell Analysis of Human Natural Killer Cell Heterogeneity. Nature Immunology, 25, 1474-1488. [Google Scholar] [CrossRef] [PubMed]
[37] Wong, F. and Cox, B. (2024) Proteomics Analysis of Preeclampsia, a Systematic Review of Maternal and Fetal Compartments. Journal of Proteomics & Bioinformatics, 15, 1-25.
[38] Bartocci, A., Pollard, J.W. and Stanley, E.R. (1986) Regulation of Colony-Stimulating Factor 1 during Pregnancy. The Journal of Experimental Medicine, 164, 956-961. [Google Scholar] [CrossRef] [PubMed]
[39] Su, J., Wang, Y., Li, Q., Yin, Z., Liu, Q., Yang, L., et al. (2025) Deconvoluting the Heterogeneities of Immune Cells at the Maternal-Fetal Interface of Mice across Pregnancy. Reproduction, 170. [Google Scholar] [CrossRef
[40] Xiong, S., Sharkey, A.M., Kennedy, P.R., Gardner, L., Farrell, L.E., Chazara, O., et al. (2013) Maternal Uterine NK Cell-Activating Receptor KIR2DS1 Enhances Placentation. Journal of Clinical Investigation, 123, 4264-4272. [Google Scholar] [CrossRef] [PubMed]
[41] Hartweger, H. and Nussenzweig, M.C. (2022) CRISPR Comes A-Knock-In to Reprogram Antibodies in Vivo. Nature Biotechnology, 40, 1183-1184. [Google Scholar] [CrossRef] [PubMed]
[42] Dai, Y., Yuan, Z., Fan, W. and Lin, Z. (2025) Molecular Mechanism of Aberrant Decidualization in Adenomyosis Leading to Reduced Endometrial Receptivity. Frontiers in Endocrinology, 15, Article ID: 1435177. [Google Scholar] [CrossRef] [PubMed]
[43] Zhou, M., et al. (2025) Spatial-Transcriptomic and Biomechanical Modeling of the Early Maternal-Fetal Interface. Science Advances, 11.